Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engert

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Recombinant human erythropoietin in oncology: current status and further developmentsA Engert
Annals of Hematology|April 23, 2003
Clinical applications of granulocyte colony-stimulating factor: an update and summaryK Hübel, A Engert
Onkologie|March 8, 2003
Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapyK Hübel, A Engert
Mediterranean Journal of Hematology and Infectious Diseases|November 24, 2011
Therapy-related myeloid neoplasms in patients treated for hodgkin lymphomaD A Eichenauer, A Engert
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study GroupM Sieber, A Engert, V Diehl
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximabJ Boye, T Elter, A Engert
Leukemia Research|January 1, 1991
Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxinsA Engert, A Brown, P Thorpe
Current Opinion in Oncology|November 4, 1998
Issues in the treatment of Hodgkin's diseaseJ Wolf, A Engert, V Diehl
Der Internist|May 29, 2020
[Checkpoint inhibitors in Hodgkin lymphoma]S Sasse, J Momotow, A Engert
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Experimental therapy in Hodgkin's diseaseA Engert, C Pohl, V Diehl
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Recombinant human erythropoietin in oncology: current status and further developmentsA Engert
Annals of Hematology|April 23, 2003
Clinical applications of granulocyte colony-stimulating factor: an update and summaryK Hübel, A Engert
Onkologie|March 8, 2003
Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapyK Hübel, A Engert
Mediterranean Journal of Hematology and Infectious Diseases|November 24, 2011
Therapy-related myeloid neoplasms in patients treated for hodgkin lymphomaD A Eichenauer, A Engert
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study GroupM Sieber, A Engert, V Diehl
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximabJ Boye, T Elter, A Engert
Leukemia Research|January 1, 1991
Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxinsA Engert, A Brown, P Thorpe
Current Opinion in Oncology|November 4, 1998
Issues in the treatment of Hodgkin's diseaseJ Wolf, A Engert, V Diehl
Der Internist|May 29, 2020
[Checkpoint inhibitors in Hodgkin lymphoma]S Sasse, J Momotow, A Engert
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Experimental therapy in Hodgkin's diseaseA Engert, C Pohl, V Diehl
Pageof 18